date:Jul 20, 2012
Acceras main brand is Axona, which is a medical food intended for the clinical dietary management of mild to moderate Alzheimers. Axona is already on the market and prescribed to up to 30,000 people.
Our stake in Accera is a strategic step forward in building up our brain health portfolio, said Luis Cantarell, president and chief executive officer of Nestle Health Science. Axona is an innovative medical food with a well-understood mode of action and offers the potential for personalized nutritio